Skip to main content
High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.
Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs.
Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions.
Pathological evidence of Wolman's disease following hematopoietic stem cell transplantation despite correction of lysosomal acid lipase activity.
Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation.
High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience.
Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies.
Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders.
Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future.
Hematopoietic stem cell transplantation for primary immunodeficiency disease.